By Maggie Fick and Michael Erman SAN FRANCISCO, Jan 26 (Reuters) - Artificial intelligence has yet to deliver on the most ...
Researchers from The Ohio State University and the Indian Institute of Technology Madras have developed an artificial ...
At a Glance The FDA reversed its 2022 NMN ban in September 2025, allowing the $500 million ingredient back on the market ...
The development of humans and other animals unfolds gradually over time, with cells taking on specific roles and functions ...
PHILADELPHIA -- Inside a heated tent on the Children’s Hospital of Philadelphia campus, 17-month-old KJ Muldoon wiggled ...
New research suggests THC’s cognitive drawbacks may be mitigated when combined with a targeted anti-inflammatory drug. Cannabis research has highlighted a scientific paradox. Its best-known ...
Before turning to prescription drugs like Reglan, discover how simple pumping technique improvements help 73% of mothers ...
Shortly after acquiring Elektrofi to beef up its subcutaneous drug-delivery offerings, Halozyme Therapeutics has struck ...
With the FDA tightening its guidance around the production of nonbacterial beta-lactam drugs, Swedish CDMO Recipharm is ...